Sign In
Buy EKSO
$11.80
+0 (+0%)
At Close: Jun 03, 2026
Ekso Bionics (EKSO) Reports Q1 Loss, Misses Revenue Estimates
06:35pm, Monday, 05'th May 2025
Ekso Bionics (EKSO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.20 per share a year ago.
Ekso Bionics Reports First Quarter 2025 Financial Results
04:05pm, Monday, 05'th May 2025
SAN RAFAEL, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and
Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to Follow
04:30pm, Monday, 28'th Apr 2025
SAN RAFAEL, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
Bionic P&O Chosen as First Distributor of Ekso Indego® Personal Within the Orthotics & Prosthetics Industry
08:16am, Wednesday, 23'rd Apr 2025
SAN RAFAEL, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda
Ekso Bionics Holdings, Inc. (EKSO) Q4 2024 Earnings Call Transcript
09:44pm, Monday, 03'rd Mar 2025
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Stephen Kilmer - IR Jerome Wong - Chief Financial Officer Scott Davis - Chief
Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results
04:05pm, Monday, 03'rd Mar 2025
SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical an
Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow
04:30pm, Monday, 24'th Feb 2025
SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry
07:00am, Monday, 10'th Feb 2025
Move expected to broaden access to Ekso Bionics' portable exoskeleton device for individuals living with spinal cord injuries and other mobility challenges across the United States Move expected to br
Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19
08:04am, Monday, 18'th Nov 2024
SAN RAFAEL, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
08:00am, Tuesday, 12'th Nov 2024
SAN RAFAEL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates
06:26pm, Monday, 28'th Oct 2024
Ekso Bionics (EKSO) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.24 per share a year ago.
Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript
05:55pm, Monday, 28'th Oct 2024
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2024 Earnings Conference Call October 28, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome
Ekso Bionics Announces Third Quarter 2024 Financial Results
04:05pm, Monday, 28'th Oct 2024
SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024
08:00am, Monday, 21'st Oct 2024
SAN RAFAEL, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering
10:42pm, Thursday, 29'th Aug 2024
SAN RAFAEL, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and
